Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-009189
Filing Date
2019-10-28
Accepted
2019-10-28 08:23:31
Documents
63
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q qure-20190930x10q.htm   iXBRL 10-Q 1897372
2 EX-10.4 qure-20190930ex10458e546.htm EX-10.4 644179
3 EX-10.5 qure-20190930ex10580ec1c.htm EX-10.5 575589
4 EX-31.1 qure-20190930ex311cbe068.htm EX-31.1 18175
5 EX-31.2 qure-20190930ex312c6851e.htm EX-31.2 18077
6 EX-32.1 qure-20190930ex32126796e.htm EX-32.1 11155
  Complete submission text file 0001558370-19-009189.txt   8731291

Data Files

Seq Description Document Type Size
7 EX-101.SCH qure-20190930.xsd EX-101.SCH 50658
8 EX-101.CAL qure-20190930_cal.xml EX-101.CAL 50670
9 EX-101.DEF qure-20190930_def.xml EX-101.DEF 239037
10 EX-101.LAB qure-20190930_lab.xml EX-101.LAB 501954
11 EX-101.PRE qure-20190930_pre.xml EX-101.PRE 386149
27 EXTRACTED XBRL INSTANCE DOCUMENT qure-20190930x10q_htm.xml XML 1279766
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36294 | Film No.: 191171194
SIC: 2834 Pharmaceutical Preparations